REVIEW ARTICLE  
Eye in COVID-19: A Brief Review  
Muhammad Mohsin Ali1, Qudsia Anwar Dar2, Zahid Kamal Siddiqui3, Alishba Khan4  
1-4King Edward Medical University, Mayo Hospital, Lahore  
ABSTRACT  
This is a brief review covering the currently available literature on ocular manifestations of COVID-19, and  
prevention strategies for ophthalmologists. A literature search was carried out of Pubmed, Google Scholar and  
WHO database of publications on COVID. Keywords used in the search were eye, ocular manifestations,  
ophthalmology, COVID-19, nCoV-2019, and coronavirus disease. All available articles were reviewed and those  
pertinent to the study topic were included. Considering the dearth of information available, ophthalmology journals  
were also searched separately for relevant articles. Major ocular manifestation of COVID reported in literature is  
red eye, which usually presents before the onset of respiratory symptoms. Since the eye can be a possible  
transmission route for SARS-CoV-2, infection control measures should be undertaken by ophthalmologists,  
including use of personal protection equipment and eye/face covering. A framework for structuring  
ophthalmological services during the COVID pandemic is also presented in this review.  
Key Words: COVID-19, Ophthalmologist, Conjunctivitis.  
How to Cite this Article: Ali MM, Dar QA, Siddiqui ZK, Khan A. The Eye in COVID-19: A Brief Review. Pak J  
Ophthalmol. 2020; 36 (3): 308-311.  
Doi: 10.36351/pjo.v36i3.1040  
INTRODUCTION  
carriers reported in the literature as well; or it can lead  
to acute respiratory distress syndrome (ARDS), against  
its spread3. COVID-19 initially presents as fever,  
cough, dyspnea, fatigue and myalgias; the clinical  
course may remain mild, with asymptomatic  
associated with need for ventilator support and high  
overall mortality4.  
The COVID-19 pandemic, caused by the SARS CoV-  
2 virus, a member of the beta coronavirus genus, has  
led to widespread public health concerns across the  
globe1. According to the WHO global situation report  
of 10th April 2020, there are more than 1.5 million  
confirmed cases with almost ninety two thousand  
deaths globally2. In South East Asia, 12,978 confirmed  
cases have been reported so far, with 569 deaths due to  
COVID-9; considering the pattern of disease spread  
across the European region and America, this number  
is only expected to rise with time.  
Ocular manifestations have also been reported in  
COVID-19, and have been purported by some to be  
the earliest sign of the disease in symptomatic  
individuals5. Previously other respiratory viruses,  
especially influenza, have been shown to use the eye  
as a portal of entry, with the H7 subtype having a  
particular ocular tropism 6. Considering the scarcity of  
personal protection equipment (PPE), the mode of  
transmission through respiratory droplets, and the  
highly infectious nature of the disease, it is imperative  
that these manifestations are not overlooked.  
Many common public health concerns have been  
raised regarding COVID-19, especially its mode of  
transmission, symptoms, and preventive measures  
Correspondence to: Muhammad Mohsin Ali  
King Edward Medical University, Mayo Hospital Lahore  
Email: mohsinali@kemu.edu.pk  
We present here a brief review of major ocular  
manifestations in COVID-19 as well as preventive  
measures that can be undertaken by healthcare  
professionals (HCPs) in this regard. We also provide a  
basic framework to be followed while planning  
Received: April 14, 2020  
Accepted: May 4, 2020  
Revised: May 4, 2020  
308  
Pakistan Journal of Ophthalmology, 2020, Vol. 36 (3): 308-311  
Eye in COVID-19: A Brief Review  
delivery of healthcare within a COVID-19 affected  
healthcare system.  
report from Thailand, out of 48 patients who tested  
positive for SARS-CoV-2 and underwent a complete  
ocular examination including direct ophthalmoscopy  
and corneal scrapings in suspected cases, no ocular  
manifestations were found9.  
MATERIAL AND METHODS  
A literature search was carried out using Pubmed,  
Google Scholar and WHO database of publications on  
COVID. Keywords used in the search were eye, ocular  
manifestations, ophthalmology, COVID-19, nCoV-  
2019, and coronavirus disease. All available articles  
were reviewed and those pertinent to the study topic  
were included. Considering the dearth of information  
available, ophthalmology journals were also searched  
separately for relevant articles.  
Apart from anecdotal evidence for red eye as a  
manifestation of COVID-19, no objective evidence is  
available regarding any other ocular signs and  
symptoms. However, considering the ocular  
manifestations reported with other coronaviruses  
previously, especially SARS10, it is imperative that  
medical practitioners should be on the lookout for  
suspicious ocular symptoms in patients with suspected  
or confirmed COVID-19, and that such patients should  
undergo a complete ocular examination, conjunctival  
swabs, and follow up ocular examination as well.  
The earliest ocular manifestation of COVID-19,  
reported by Guangfa Wang, a member of the Chinese  
National Expert Panel on Pneumonia in January 2020,  
included redness of the eyes, which had occurred  
several days prior to the onset of pneumonia and  
positive testing for SARS-CoV-25. This raised the  
suspicion that the exposed eye could be a possible  
extra-respiratory transmission route for the virus,  
following which the Chinese CDC recommended eye  
protection to healthcare workers exposed to COVID-  
19.  
Preventive Measures for Healthcare  
Professionals  
The first ocular manifestations were reported from  
centers where wearing eye protection was not within  
the normal routine of donning personal protection  
equipment5. In many countries, ophthalmologists do  
not normally use eye protection in the form of goggles  
or face shields during daily clinical activities9. In the  
context of COVID-19, it was found in a survey  
conducted on accident and emergency (A&E)  
ophthalmologists that 79% had no training in using  
PPE; more than 50% were dissatisfied with the  
guidelines that did not recommend PPE for  
ophthalmology practitioners; and a similar number  
were unaware of the recommended PPE for close  
patient contact11. Considering that ophthalmologists  
have close contact with patients for slit lamp eye  
examinations, and face a high burden of eye disease on  
daily basis, it is important that they are aware of the  
correct preventive measures that need to be undertaken  
in the healthcare settings. Infection control measures  
for ophthalmologists need to be stepped up, with  
proper training of healthcare staff and utilization of a  
triage system and telemedical services to reduce  
An observational study was carried out in a  
Chinese hospital on 114 patients who underwent  
consecutive nasopharyngeal and conjunctival swab  
tests for detection of SARS-CoV-2 on RT-PCR. The  
study reported negative conjunctival samples from all  
the patients, 79% of whom had tested positive for  
COVID-19 on nasopharyngeal swabs. Furthermore, no  
obvious ocular symptoms were documented in the  
study; it was suggested, however, that the presence of  
the virus in the conjunctival sac or tear fluid might  
occur for a very brief period of time, and in suspected  
patients presenting with red eye, testing with  
conjunctival swabs concurrent with nasopharyngeal  
swabs would hold diagnostic significance6,7.  
In a non-peer reviewed retrospective cohort study,  
67 confirmed and suspected cases of COVID-19  
unnecessary patient presentation12,13  
.
underwent  
concurrent  
nasopharyngeal  
and  
conjunctival swabs; 1 patient with confirmed COVID  
had positive conjunctival PCR for SARS-Cov-2, while  
2 others had probable positive PCR results from  
conjunctival swabs. Interestingly, however, none of  
the patients with positive conjunctival swabs had any  
ocular manifestations, and the patient who reported red  
eye prior to testing were found negative for SARS-  
CoV-2 on conjunctival swab PCR8. In another brief  
Based on the guidelines issued by the Royal  
College of Ophthalmologists14 and the American  
Academy of Ophthalmology (AAO)15, we present the  
following brief recommendations for prevention of  
COVID-19 in ophthalmology healthcare workers:  
1. Eye protection and face protection should be used  
by HCPs working in the inpatient department  
Pakistan Journal of Ophthalmology, 2020, Vol. 36 (3): 308-311  
309  
Muhammad Mohsin Ali, et al  
within two meters of patients, in emergency and  
acute hospital clinics and outpatient departments,  
and in operation theaters or high dependency units,  
especially when performing an eye review. For  
aerosol generating procedures such as intubation,  
single use eye protection must be utilized.  
avoided; I-care tonometry can be used instead;  
whereas Goldmann applanation tonometry should  
be used only when essential.  
7. Investigations such as visual field testing, ocular  
computed tomography (OCT) and ultrasound B-  
scan should be avoided unless absolutely essential.  
8. Indirect ophthalmoscopy should be used in  
preference to slit lamp biomicroscopy whenever  
appropriate.  
Framework for Delivering Ophthalmology  
Services  
In lower middle income countries, there is a high  
burden of ophthalmic diseases. Considering the case of  
Pakistan, the burden of disease is on the rise, with  
almost 4.3% of the total population suffering from  
visual deficiency, ranging from moderate loss to  
complete blindness16. In a study conducted at a public  
sector hospital in Pakistan, ocular emergencies  
accounted for 20% of all ophthalmology department  
admissions, with 55% of the emergencies being  
traumatic17. Considering the high number of ocular  
Fig. 1: Framework for provision of eye healthcare during COVID-19.  
*standard precautions include frequent hand washing, use of PPE,  
cough etiquette, disinfection of examination rooms.  
emergency  
presentations,  
a
framework  
of  
ophthalmology services has been devised—this frame  
work is in accordance with the guidelines set forth by  
the AAO and the Royal College of Ophthalmologists.  
Ocular emergencies requiring urgent review include  
the following: acute glaucoma (IOP > 40 mm Hg);  
rapidly progressive glaucoma; wet active age-related  
macular degeneration (ARMD); severe uveitis; acute  
retinal detachments; proliferative diabetic retinopathy;  
retinopathy of prematurity; endophthalmitis; sight  
threatening trauma; orbital cellulitis; and giant cell  
arteritis, among others. If the patient is below 70 years  
old, with the disease being in only or better seeing eye,  
treatment must continue for these patients, while  
2. Slit lamp barrier or breath guard must be used  
whenever slit lamp examination needs to be  
performed in the inpatient or outpatient  
department or acute eye clinics.  
3. Disposable gloves, aprons and water resistant  
gowns must be donned by professionals working  
in the operation theaters. Gowns are not essential  
for inpatient areas and outpatient clinics.  
Similarly, respirator masks are only suitable for  
use during aerosol generating procedures or in  
high dependency units; simple fluid resistant  
surgical masks should be used in all other places.  
keeping standard precautions in view18,19,20  
.
CONCLUSION  
4. A minimum distance of two meters should be kept  
from the patient except when clinical examination  
is required.  
COVID-19 is currently impacting the global  
healthcare landscapein an unprecedented way. While  
ocular manifestations of COVID-19 have not been  
reported widely in literature, the eye remains a  
possible transmission route for SARS-CoV-2.  
Healthcare workers and ophthalmologists must take  
this under consideration and utilize proper eye  
protection equipment, social distancing, and infection  
control measures to reduce the impact of disease  
burden.  
5. Prior to any exam, especially in patients with  
conjunctivitis, history of fever, respiratory  
symptoms, travel, or COVID contact must be  
taken by the ophthalmologist.  
6. While checking intraocular pressure, disposable  
tonometer tips must be used by the  
ophthalmologists. Air puff tonometry should be  
310  
Pakistan Journal of Ophthalmology, 2020, Vol. 36 (3): 308-311  
Eye in COVID-19: A Brief Review  
Doi: 10.1007/s00417-020-04662-3. [Epub ahead of  
print]  
10. Chan W, Yuen K, Fan D, Lam D, Chan P, Sung J.  
Tears and conjunctival scrapings for coronavirus in  
patients with SARS. Br J Ophthalmol. 2004; 88 (7):  
968-9.  
11. Minocha A, Sim SY, Than J, Vakros G. Survey of  
ophthalmology practitioners in A&E on current  
COVID-19 guidance at three Major UK Eye Hospitals.  
Eye (Lond). 2020 Apr 7. Doi: 10.1038/s41433-020-  
0857-5. [Epub ahead of print]  
12. Lai TH, Tang EW, Chau SK, Fung KS, Li KK.  
Stepping up infection control measures in  
ophthalmology during the novel coronavirus outbreak:  
an experience from Hong Kong. Graefes Arch Clin Exp  
Ophthalmol. 2020: Doi:10.1007/s00417-020-04641-8.  
13. Hu VH, Watts E, Burton M, Kyari F, Mathenge C,  
Heidari F, et al. Protecting yourself and your patients  
from COVID-19 in eye care. Comm Eye Health, 2020;  
33 (108): S2.  
Conflict of Interest  
Authors declared no conflict of interest.  
Authors’ Designation and Contribution  
Muhammad Mohsin Ali; House Officer: Literature  
review, manuscript writing, final review.  
Qudsia Anwar Dar; Senior Registrar: Literature  
review, manuscript writing, final review.  
Zahid Kamal Siddiqui; Professor: Literature review,  
manuscript writing, final review.  
Alishba Khan; House Officer: Literature review,  
manuscript writing, final review.  
REFERENCES  
1. del Rio C, Malani PN. COVID-19—New Insights on a  
Rapidly Changing Epidemic. JAMA. 2020. Feb 28.  
Doi: 10.1001/jama.2020.3072.  
2. WHO. Coronavirus Disease 2019 (COVID-19)  
Situation Report – 81: WHO; 2020 [cited 2020 10th  
April]. Available from:  
0200410-sitrep-81-covid-19.pdf.  
3. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019  
novel coronavirus of pneumonia in Wuhan, China:  
emerging attack and management strategies. Clin Trans  
Med. 2020; 9 (1): 19.  
4. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia  
Z. Review of the Clinical Characteristics of  
Coronavirus Disease 2019 (COVID-19). JGen Intern  
Med. 2020: Mar 4. Doi: 10.1007/s11606-020-05762-w.  
[Epub ahead of print]1-5.  
5. Lu C-w, Liu X-f, Jia Z-f. 2019-nCoV transmission  
through the ocular surface must not be ignored. Lancet  
(London, England). 2020; 395 (10224): e39.  
6. Belser JA, Lash RR, Garg S, Tumpey TM, Maines  
TR. The eyes have it: influenza virus infection beyond  
the respiratory tract. Lancet Infect Dis. 2018; 18 (7):  
e220-e7.  
7. Deng C, Yang Y, Chen H, Chen W, Chen Z, Ma K,  
et al. Ocular detection of SARS-CoV-2 in 114 cases of  
COVID-19 pneumonia in Wuhan, China: an  
observational study (2/19/2020). 10.2139/ssrn.3543587.  
8. Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic  
evidence against the interpersonal transmission of 2019  
novel coronavirus through conjunctiva. MedRxiv.  
0.02.11.20021956.  
14. RCOphth COVID-19 Clinical Guidance for  
Ophthalmologists  
The Royal College of  
Ophthalmologists. [online] The Royal College of  
Ophthalmologists. Available at:  
response/.> [Accessed 23 May 2020].  
15. Medscape. 2020. COVID-19 Guidance for  
Ophthalmologists (AAO, 2020). [online] Available at:  
<https://reference.medscape.com/viewarticle/927354>  
[Accessed 23 May 2020].  
16. Hassan B, Ahmed R, Li B, Noor A, ul Hassan Z. A  
comprehensive study capturing vision loss burden in  
Pakistan (1990-2025): Findings from the Global Burden  
of Disease (GBD) 2017 Study. PloS one. 2019; 14 (5).  
17. Qayyum A, Khokhar AH, Achakzai AS. Prevalence  
of ocular emergencies in Quetta-Balochistan. Pak JMed  
Sci. 2009; 3 (3): 43-5.  
18. RCOphth. Management of Ophthalmology Services  
during the Covid pandemic 2020. [online] Available  
content/uploads/2020/03/RCOphth-Management-of-  
Ophthalmology-Services-during-the-Covid-pandemic-  
280320.pdf> [Accessed 23 May 2020].  
19. RCOphth: Management of Ophthalmology Services  
during the Covid pandemic. 2020. [online] Available  
onavirus-covid-19-list-of-guidance> [Accessed 23 May  
2020].  
20. RCOpath: Management of Ophthalmology Services  
during the Covid pandemic, 2020. [online] Available  
and-resources-for-ophthalmologists > [Accessed 23  
May 2020].  
9. Mungmungpuntipantip R, Wiwanitkit V. Ocular  
manifestation, eye protection, and COVID-19. Graefes  
Arch Clin Exp Ophthalmol. 2020 Mar 30: 1.  
.…….  
Pakistan Journal of Ophthalmology, 2020, Vol. 36 (3): 308-311  
311